Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive data.
The decision came to light following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson later clarified that the United States was demanding access to health data for scientific study and profit while refused to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more negotiations to find a deal suitable to all parties so the country's critical HIV treatment initiative can continue.
Wider Context
This rejection follows a comparable case in Kenya, where a high court halted a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to boost openness and accountability.
As per reports, 16 African countries have so far signed similar agreements, constituting over $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the end products would be accessible to our people if a future pandemic arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting systems previously set up via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This framework is intended to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage further discussions with our American counterparts on how future co-operation could be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that talks must proceed since a large portion of the country's Aids initiatives were funded by international support.
"If technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group commented.
This impasse underscores the ongoing challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.